Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pain Biomarker Study: Changes in Circulating Pain Signalling Molecules With Activation of Pain Receptors

NCT03511846 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT03511846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03511846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pain Biomarker Study: Changes in Circulating Pain Signalling Molecules With Activation of Pain Receptors
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
March 21, 2018
Completion date
May 31, 2028
Enrollment
371 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cluster headache, hemicrania continua, migraine, paroxysmal hemicrania, short-lasting unilateral neuralgiform headache with conjunctival injection and tearing, sunct, trigeminal autonomic cephalgia